PX1 Research supplies USA-manufactured, research-grade Bronchogen tetrapeptide for high-precision laboratory assays. Formulated strictly for in vitro and preclinical research, our Bronchogen batches feature lot-specific HPLC/MS purity validation and full endotoxin documentation to support reliable investigation into respiratory epithelial dynamics and cellular stress response pathways.
PX1 Research supplies USA-manufactured, research-grade Bronchogen tetrapeptide for high-precision laboratory assays. Formulated strictly for in vitro and preclinical research, our Bronchogen batches feature lot-specific HPLC/MS purity validation and full endotoxin documentation to support reliable investigation into respiratory epithelial dynamics and cellular stress response pathways.
When purchasing Bronchogen for examining cellular mechanisms, researchers require analytical-grade purity verified by independent liquid chromatography and mass spectrometry. Sourcing Bronchogen viral mechanisms for sale through PX1 Research guarantees a minimum 98% peptide purity with batch-specific Certificates of Analysis (COAs) detailing endotoxin levels and sequence identity for non-clinical research applications.
Bronchogen (Ala-Glu-Asp-Leu) is evaluated in preclinical settings to understand how short regulatory peptides interact with genomic DNA, modulate expression of cell-adhesion proteins, and alter host-pathogen stress responses in bronchial epithelial tissues. PX1 Research delivers standardized, lyophilized Bronchogen synthesized in USA-based, GMP-compliant facilities to ensure reproducibility across experimental models.
Bronchogen is a short synthetic tetrapeptide composed of the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-leucine (Ala-Glu-Asp-Leu). Belonging to the class of short peptide bioregulators, its molecular design allows for potential direct interaction with the major and minor grooves of DNA, as well as specific histones within respiratory cell nuclei.
In cell-free and cellular research peptides assays, low-molecular-weight peptides like Bronchogen demonstrate structural stability and high affinity for nuclear chromatin. Preclinical studies suggest that this interaction can epigenetically modulate gene transcription without altering the underlying nucleotide sequence, providing a controlled model for studying targeted gene reactivation during inflammatory or viral challenges.
Preclinical investigations focusing on bronchial cell lines (such as BEAS-2B and primary human airway epithelial cultures) indicate that Bronchogen plays a key role in modulating local inflammatory cascades. In vitro assays demonstrate that exposure to Bronchogen can alter the production of pro-inflammatory cytokines, including IL-6 and IL-8, when cells are subjected to endotoxin or simulated viral stress.
Furthermore, animal models evaluating lung tissue morphology show that administration of research-grade Bronchogen supports structural preservation of alveolar membranes and cilia motility under oxidative stress. These findings position the compound as a valuable tool for investigating host-pathogen dynamics, pulmonary remodeling, and epithelial barrier preservation in response to viral mimetic challenges.
Viral pathogens frequently exploit host cell surface receptors and alter tight junction integrity to facilitate entry and replication. In vitro models utilizing the Bronchogen research compound aim to clarify whether short regulatory sequences can influence the expression of receptor proteins, such as ACE2 or specific integrins, on airway epithelial surfaces.
Research teams utilize Bronchogen to measure changes in transepithelial electrical resistance (TEER) and expression of zonula occludens-1 (ZO-1) during viral challenge experiments. Preliminary data suggest that peptide pre-treatment may stabilize junctional complexes, mitigating pathogen-induced barrier breakdown. Explore detailed assay methodologies in our laboratory research library.
To contextualize Bronchogen within the broader spectrum of regulatory peptides, laboratories frequently conduct comparative assays alongside other short synthetic sequences targeting immune or epithelial modulation.
While Bronchogen specifically targets pulmonary and respiratory epithelial gene expression, Thymogen research compound focuses primarily on T-cell differentiation and systemic immune signaling pathways. Similarly, Epitalon bioregulator regulates telomerase activity and neuroendocrine rhythms, whereas KPV peptide exerts direct anti-inflammatory downstream signals via nuclear factor-kappa B (NF-κB) inhibition. Evaluating these compounds in parallel allows researchers to delineate tissue-specific peptide responses from generalized immunomodulatory signaling.
To maintain structural integrity and prevent hydrolytic degradation, lyophilized Bronchogen should be stored at -20°C upon receipt. For long-term preservation prior to assay preparation, storage at -80°C in a desiccated environment is recommended to protect against atmospheric moisture.
Reconstitution should be performed under sterile laminar flow using bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle inversion or swirling is advised to dissolve the cake completely. Once reconstituted, aliquots should be frozen at -20°C to eliminate freeze-thaw cycles that could compromise peptide stability. Detailed technical specs can be reviewed via a bulk research account.
Rigorous analytical verification is vital when investigating subtle transcriptional and viral-host mechanisms. PX1 Research subjects every batch of Bronchogen to rigorous analytical peptide purity standards, utilizing reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity (>98%) and electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular mass.
Because lipopolysaccharides (LPS) and bacterial endotoxins can confound immunological and viral host assays, PX1 Research conducts quantitative Chromogenic LAL testing on all lots. Only batches meeting strict endotoxin limits (<0.01 EU/μg) are approved for laboratory distribution, ensuring your research data remains uncompromised by external artifacts.
PX1 Research is dedicated exclusively to supporting the scientific community with reliable, high-purity research compounds synthesized within the USA. Operating out of state-of-the-art facilities compliant with ISO 17025 and cGMP standards, we guarantee lot-to-lot consistency critical for peer-reviewed studies.
All orders ship directly from our California and Arizona fulfillment hubs with same-day dispatch for orders placed Monday through Friday before cutoff times. Each vial is accompanied by complete, transparent documentation, giving research teams full confidence in their supply chain.
What is the sequence and molecular weight of Bronchogen?
Bronchogen is a tetrapeptide with the primary amino acid sequence Ala-Glu-Asp-Leu (L-alanyl-L-glutamyl-L-aspartyl-L-leucine) and a calculated molecular weight of approximately 446.45 g/mol.
Is Bronchogen supplied for human clinical use or personal administration?
No. Bronchogen provided by PX1 Research is strictly designated for laboratory research use only (RUO), including in vitro cellular assays and non-human animal models. It is not intended for human or veterinary use, therapy, or diagnosis.
How does PX1 Research verify Bronchogen purity?
Every lot undergoes independent testing via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity (>98%) and Mass Spectrometry (MS) to confirm exact molecular weight and sequence identity. Certificates of Analysis are published per lot.
What solvent is recommended for reconstituting Bronchogen in vitro assays?
Standard laboratory solvents such as sterile water for injection, bacteriostatic water, or sterile phosphate-buffered saline (PBS, pH 7.4) are commonly used depending on the specific cell culture or analytical protocol requirements.
Are endotoxin levels tested for PX1 Research peptides?
Yes. Every production batch undergoes quantitative Kinetic Chromogenic LAL testing to verify that bacterial endotoxin levels remain under strict threshold limits (<0.01 EU/μg), preventing unwanted cellular activation during assays.
What are the recommended storage conditions for lyophilized Bronchogen?
Lyophilized Bronchogen should be stored desiccated at -20°C for short-to-medium term storage, or at -80°C for long-term preservation. Reconstituted stock solutions should be aliquoted and kept at -20°C to avoid repeated freeze-thaw cycles.
Where are PX1 Research compounds synthesized and shipped from?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from our primary distribution hubs located in California and Arizona with same-day shipping on weekdays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.